Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy

ClinicalTrials.gov ID: NCT05869773

Public ClinicalTrials.gov record NCT05869773. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 4:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to Xywav

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The aim of this study is to quantify the change in blood pressure when participants with narcolepsy treated with high-sodium oxybate are transitioned to Xywav, a low-sodium oxybate. The results of this study may provide health care providers (HCPs), patients, and payers with important new information regarding BP changes related to differences in sodium content between available oxybates for the treatment of narcolepsy.

Study identification

NCT ID
NCT05869773
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
155 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 26, 2023 (Actual)
Primary completion
Feb 25, 2025 (Actual)
Completion
Mar 10, 2025 (Actual)
Last update posted
Apr 24, 2026

2023 – 2025

United States locations

U.S. sites
31
U.S. states
16
U.S. cities
30
Facility City State ZIP Site status
Science 37 Culver City California 90230 —
M3 Wake Research Encino California 91436 —
So Cal Clinical Research Huntington Beach California 92647 —
Long Beach Research Institute Lakewood California 90805 —
Stanford School of Medicine Redwood City California 94063 —
TriValley Sleep Center San Ramon California 94583 —
SDS Clinical Trials, Inc. Santa Ana California 92705 —
FWD Clinical Research Boca Raton Florida 33486 —
Meris Clinical Research, LLC Brandon Florida 33511 —
Ocean Wellness Center Miami Florida 33169 —
Serenity Research Center LLC Miami Florida 33176 —
Florida Pediatric Research Institute, LLC Orlando Florida 32804 —
Sleep Practitioners, LLC Macon Georgia 31210 —
Saltzer Medical Group Nampa Idaho 83686 —
University of Louisville Louisville Kentucky 40202 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Neurocare, Inc Newton Massachusetts 02459 —
Sparrow Health System Lansing Michigan 48911 —
Bryan Medical Center Lincoln Nebraska 68506 —
Henderson Clinical Trials LLC Henderson Nevada 89052 —
Advanced Respiratory and Sleep Medicine, PLLC Huntersville North Carolina 28078 —
Intrepid Research, LLC Cincinnati Ohio 45245 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
Ohio Sleep Medicine and Neuroscience Dublin Ohio 43017 —
OHSU Hospital Portland Oregon 97239 —
Abington Neurological Associates, LTD Abington Pennsylvania 19001 —
Bogan Sleep Consultants, LLC Columbia South Carolina 29201 —
Velocity Clinical Research, Greenville Greenville South Carolina 29615 —
Clinical Research of Rock Hill Rock Hill South Carolina 29732 —
FutureSearch Trials of Neurology Austin Texas 78731 —
Sleep Therapy & Research Center San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05869773, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05869773 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →